Healthcare Giant Roche Joins Push for Antibody Coronavirus Test
April 17 2020 - 2:46AM
Dow Jones News
By Denise Roland
Swiss healthcare giant Roche Holding AG is joining efforts to
develop an antibody test for the coronavirus with plans to launch a
product in early May.
Antibody tests are seen by many governments around the world as
key to better understanding the spread of mild and asymptomatic
cases of Covid-19. They search for specific antibodies--tailor made
proteins made by the body in response to infection--as a sign that
a person has encountered, and recovered from, the virus. They are
different from the swab tests used to diagnose a current
infection.
Roche, the world's biggest diagnostics company by revenue, is
one of dozens of groups developing antibody tests but its size
means it can scale up quickly. The company says it will be able to
churn out test kits in the "high double digit millions" per month,
according to Thomas Schinecker, who leads Roche's diagnostics
business. The tests, made in Germany, will run on the company's
diagnostics machines that are already found in labs around the
world.
A number of commercial antibody tests from smaller companies are
already available but many aren't deemed accurate enough by
governments. Mr. Schinecker said he was confident that Roche's
test, which is still under development, would clear the bar. Roche
plans to seek emergency use authorization from the Food and Drug
Administration. "Most of the known players will make sure they come
with a test that is very precise," he said.
Write to Denise Roland at Denise.Roland@wsj.com
(END) Dow Jones Newswires
April 17, 2020 02:31 ET (06:31 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Apr 2023 to Apr 2024